Page last updated: 2024-11-05

w 7 and Cancer of Pituitary

w 7 has been researched along with Cancer of Pituitary in 2 studies

W 7: RN given refers to parent cpd; structure; calmodulin antagonist

Research Excerpts

ExcerptRelevanceReference
"When trifluoperazine was incubated with cytosol, both the high and low affinity forms of cyclic AMP phosphodiesterase were inhibited competitively with calculated Ki of 4."1.27Effects of calmodulin antagonists on hormone release and cyclic AMP levels in GH3 pituitary cells. ( Gautvik, KM; Gordeladze, J; Haug, E; Sand, O; Sletholt, K, 1987)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beaubien, BC1
Herbert, E1
Sletholt, K1
Haug, E1
Gordeladze, J1
Sand, O1
Gautvik, KM1

Other Studies

2 other studies available for w 7 and Cancer of Pituitary

ArticleYear
Modulation of beta-endorphin secretion from mouse pituitary tumor cells by calmodulin inhibitor W7.
    NIDA research monograph, 1986, Volume: 75

    Topics: Animals; beta-Endorphin; Calmodulin; Cell Line; Kinetics; Mice; Pituitary Neoplasms; Sulfonamides

1986
Effects of calmodulin antagonists on hormone release and cyclic AMP levels in GH3 pituitary cells.
    Acta physiologica Scandinavica, 1987, Volume: 130, Issue:2

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Animals; Cell Division; Cell Line; Chlorprom

1987